KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Inventory (2018 - 2025)

Historic Inventory for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $32.9 million.

  • Twist Bioscience's Inventory rose 3999.49% to $32.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $32.9 million, marking a year-over-year increase of 3999.49%. This contributed to the annual value of $28.3 million for FY2025, which is 1757.21% up from last year.
  • As of Q4 2025, Twist Bioscience's Inventory stood at $32.9 million, which was up 3999.49% from $28.3 million recorded in Q3 2025.
  • Twist Bioscience's Inventory's 5-year high stood at $44.6 million during Q4 2022, with a 5-year trough of $15.8 million in Q1 2021.
  • In the last 5 years, Twist Bioscience's Inventory had a median value of $31.3 million in 2021 and averaged $31.7 million.
  • As far as peak fluctuations go, Twist Bioscience's Inventory surged by 20008.95% in 2021, and later crashed by 3132.74% in 2025.
  • Quarter analysis of 5 years shows Twist Bioscience's Inventory stood at $40.2 million in 2021, then increased by 10.83% to $44.6 million in 2022, then plummeted by 30.8% to $30.9 million in 2023, then dropped by 23.8% to $23.5 million in 2024, then surged by 39.99% to $32.9 million in 2025.
  • Its last three reported values are $32.9 million in Q4 2025, $28.3 million for Q3 2025, and $25.9 million during Q2 2025.